CM
Therapeutic Areas
180 Life Sciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Anti-TNF (Local Administration) | Dupuytren's Disease (Early Stage) | Phase 2b |
| Synthetic Cannabinoid Analogs | Chronic Pain & Inflammation | Pre-clinical |
| α7nAChR Program | Inflammatory Bowel Disease (IBD) & Other Inflammatory Conditions | Pre-clinical |
Leadership Team at 180 Life Sciences
DJ
Dr. James N. Woody
Chief Executive Officer & Director
DL
Dr. Lawrence Steinman
Chairman of the Scientific Advisory Board & Co-Founder
PS
Prof. Sir Marc Feldmann
Scientific Advisory Board & Co-Founder
PJ
Prof. Jagdeep Nanchahal
Scientific Advisory Board & Co-Founder
PG
Pamela G. Marrone, Ph.D.
Board Director
OP
Ozan Pamir
Interim Chief Financial Officer
DJ
Dr. Jonathan Rothbard
Chief Scientific Officer
DJ
Dr. John A. L. Meldrum
Board Director
KJ
Kevin J. Connors
Board Director